Clinical Observation of Luspatercept in Treatment of Chinese Adult β-thalassaemia Patients With TD β-thalassemia
Condition(s):Effect of DrugLast Updated:December 22, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Effect of DrugLast Updated:December 22, 2023Recruiting
Condition(s):Myelodysplastic Syndromes (MDS); Beta-thalassemia; Myeloproliferative Neoplasm(MPN)-Associated MyelofibrosisLast Updated:February 15, 2024Recruiting
Condition(s):Myeloid DysplasiaLast Updated:February 15, 2023Completed
Condition(s):Primary Myelofibrosis; AnemiaLast Updated:August 24, 2023Completed
Condition(s):Myelodysplastic SyndromesLast Updated:October 12, 2023Active, not recruiting
Condition(s):Myelodysplastic SyndromesLast Updated:June 15, 2023Completed
Condition(s):MDS; Myelodysplastic SyndromesLast Updated:January 3, 2024Recruiting
Condition(s):Myelodysplastic Syndromes; AnemiaLast Updated:January 31, 2024Recruiting
Condition(s):Thalassemia Major; Transfusion-dependent AnemiaLast Updated:July 18, 2022Recruiting
Condition(s):Myelodysplastic Syndromes; Myeloproliferative Neoplasm; AnemiaLast Updated:January 25, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.